• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION SYNERGY XD; CORONARY DRUG-ELUTING STENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION SYNERGY XD; CORONARY DRUG-ELUTING STENT Back to Search Results
Catalog Number H7493941838300
Device Problems Complete Blockage (1094); Coagulation in Device or Device Ingredient (1096)
Patient Problems Chest Pain (1776); Myocardial Infarction (1969); Sepsis (2067); Thrombosis/Thrombus (4440)
Event Date 05/07/2021
Event Type  Injury  
Event Description
On (b)(6) 2021, patient was transferred to our hospital for nonstemi.To cath lab where films reveal a total occlusion of mid lad, which appeared to be a chronic total occlusion but patient reports chest pain for only 5 days.The lesion was pre dilated with a 2.5x20 emerge otw, and a 3x30 emerge rx, multiple inflations.A 3x38 synergy xd was deployed and it's balloon re-inflated to post dilate.A 3x20 synergy xd deployed more proximal and it's balloon re-inflated to post dilate.Patient did well, and dc'd (b)(6) 2021 on asa 325 mg qd and plavix 75 mg qd.Patient admitted to hospital for uti sepsis (b)(6) 2021, no complaints of chest pain during this admission.On (b)(6) 2021, patient presents to outlying er with chest pain of one hour duration.Diagnosed with stemi and transferred to our cath lab for emergent pci.Previously placed stents with 100% thrombotic occlusion.Patient stated that she had faithfully taken asa and plavix with no missed doses.Thrombectomy performed, and a 3.5x30 nc emerge rx used.Final results with 0% residual stenosis and timi iii flow.Patient did well, and was dc'd (b)(6) 2021 on asa 325 mg qd and brilinta 90 mg bid.Fda safety report id # (b)(4).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SYNERGY XD
Type of Device
CORONARY DRUG-ELUTING STENT
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
MDR Report Key12353612
MDR Text Key267832344
Report NumberMW5103380
Device Sequence Number1
Product Code NIQ
Reporter Country CodeUS
Number of Events Reported1
Summary Report (Y/N)N
Report Source Voluntary
Reporter Occupation Nurse
Type of Report Initial
Report Date 08/18/2021
2 Devices were Involved in the Event: 1   2  
1 Patient was Involved in the Event
Date FDA Received08/20/2021
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date01/25/2022
Device Catalogue NumberH7493941838300
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Was Device Evaluated by Manufacturer? No Information
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage N
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age62 YR
Patient Weight100
-
-